<DOC>
	<DOCNO>NCT01071135</DOCNO>
	<brief_summary>The purpose study determine effect Quetiapine patient schizophrenia induce cannabis abuse .</brief_summary>
	<brief_title>Quetiapine XR Schizophrenic Patients</brief_title>
	<detailed_description>To evaluate effect quetiapine positive negative symptom schizophrenia schizophrenic patient associate cannabis abuse patient psychotic disorder cannabis abuse .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>1 . Females and/or male age 18 60 year . 2 . Provision write informed consent . In case acute psychosis write informed consent obtain legal representative patient , applicable two independent physician involve study . When patient recovers , write informed consent sign patient . 3 . A diagnosis schizophrenia ( ICD10 : F20.0 , F20.1 , F20.2 , F20.4 , F20.5 ) associate cannabis abuse and/or psychotic disorder ( e.g . schizophrenia ) cannabis ( ICD 10 : F12.5 , F12.7 ) . 4 . A score least 15 positive scale PANSS . 5 . Female patient childbearing potential must use reliable method contraception ( i.e . contraceptive pill , contraceptive coil , sterilization , hysterectomy ) negative blood human chorionic gonadotropin ( HCG ) test enrollment . 6 . Able understand comply requirement study . In case acute psychosis patient include expect understand requirement healthy condition . 1 . Pregnancy lactation . 2 . Any ICD10 Fcriteria define inclusion criterion . 3 . Patients , opinion investigator , pose imminent risk suicide danger others . 4 . Known intolerance lack response quetiapine fumarate judge investigator . 5 . Use follow cytochrome P450 3A4 inhibitor 14 day precede enrollment , include limited : ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , troleandomycin , indinavir , nelfinavir , ritonavir , fluvoxamine saquinavir . 6 . Use follow cytochrome P450 3A4 inducer 14 day precede enrollment include limited : phenytoin , carbamazepine , barbiturate , rifampin , St. John 's Wort , glucocorticoid . 7 . Patients require treatment one additional neuroleptic quetiapine . 8 . Administration depot antipsychotic injection within one dose interval ( depot ) randomisation . 9 . Substance alcohol dependence within 4 week prior enrolment , enrollment study ( except cannabis , caffeine nicotine dependence ) , define DSMIV criterion . 10 . Medical condition would affect absorption , distribution , metabolism , excretion study treatment . 11 . Unstable inadequately treat medical illness ( e.g . congestive heart failure , angina pectoris , hypertension ) judge investigator . 12 . An absolute neutrophil count ( ANC ) ≤ 1.5 x 109 per liter . 13 . Involvement plan conduct study . 14 . Previous enrollment randomisation treatment present study . 15 . A patient Diabetes Mellitus ( DM ) fulfil one follow criterion : Unstable DM define enrollment glycosylated haemoglobin ( HbA1c ) &gt; 8.5 % . Admitted hospital treatment DM DM relate illness past 12 week . Not physicians care DM . Physicians responsible patient´s DM care indicate patient´s DM control . Physician responsible patient´s DM care approve patient´s participation study . Has dose oral hypoglycaemic drug ( ) and/or diet 4 week prior inclusion . For thiazolidinediones ( glitazones ) period least 8 week . Taking insulin whose daily dose one occasion past 4 week 10 % mean dose precede 4 week . Note : If diabetic patient meet one criterion , patient exclude even treat physician believe patient stable participate study . 16 . Previous treatment study medication within last 4 week prior enrollment study . 17 . Participation another drug trial within 4 week prior enrollment study current participation another clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>